Net-benefit regression with censored cost-effectiveness data from randomized or observational studies

DOI10.1002/SIM.9486zbMATH Open1547.62181MaRDI QIDQ6628515

Shuai Chen, Jeffrey S. Hoch

Publication date: 29 October 2024

Published in: Statistics in Medicine (Search for Journal in Brave)

zbMATH Keywords

censored datadouble robustnessinverse-probability weightingcost-effectiveness analysisnet-benefit regression

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• Title not available (Why is that?)
• On Estimating Medical Cost and Incremental Cost-Effectiveness Ratios with Censored Data
• Applied Econometrics with R
• Model-Based Direct Adjustment
• THE DISTRIBUTION OF THE INDEX IN A NORMAL BIVARIATE POPULATION
• Estimating Medical Costs from Incomplete Follow-Up Data
• Calibration Regression of Censored Lifetime Medical Cost
• Linear regression analysis of censored medical costs
• Estimating medical costs with censored data
• A Study on Confidence Intervals for Incremental Cost‐Effectiveness Ratios
• The Kaplan–Meier Estimator as an Inverse-Probability-of-Censoring Weighted Average
• Estimating marginal and incremental effects on health outcomes using flexible link and variance function models
• Super Learner
• A Generalization of Sampling Without Replacement From a Finite Universe
• The Elements of Statistical Learning

This page was built for publication: Net-benefit regression with censored cost-effectiveness data from randomized or observational studies

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6628515)